Details for 2020759361

Up to date per 03.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON LEBERKREBS UNTER VERWENDUNG EINES ORAL VERABREICHTEN DIOXOLAN-NUKLEOTIDS IN KOMBINATION MIT EINEM MONOKLONALEN ANTI-PD1- ODER ANTI-PDL1-ANTIKÖRPER

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020759361

EP Publication Number

3927347

E-Number

1643901

Language

PCT Number

SE20050175

Publication Date

29.12.2021 A

27.12.2023 B1

Registration Date

27.12.2023

AT Publication Date

15.01.2024

Application Date

17.02.2020

Registration Number

Priorities

18.02.2019

1950202

IPC

A61K 31/675 20060101AFI20221005BHEP

Maximum Duration of Protection

17.02.2040

Owner

Medivir AktiebolagP.O. Box 1086 141 22 HuddingeSE

Representative

No representatives present

Inventor

ALBERTELLA, Markc/o Medivir Aktiebolag Box 1086 141 22 HUDDINGESE